PEG3000
Based on 2 publication(s) in Google Scholar
PEG3000 (Polyethylene glycol 3000) is a solvent for a large number of substances. PEG3000 can be used as a carrier material and modifying agent. PEG3000 is widely used in a variety of pharmaceutical formulations.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 98.0%
- CAS. Nr.: 25322-68-3
- Molecular Weight:3000.00
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) PEG3000
More
Biologische Aktivität
The FDA has approved polyethylene glycol (PEG) for use as a vehicle or base in foods, cosmetics and pharmaceuticals, including injectable, topical, rectal and nasal formulations. PEG shows little toxicity, and is eliminated from the body intact by either the kidneys (for PEGs < 30 kDa) or in the faeces (for PEGs > 20 kDa). PEG lacks immunogenicity, and antibodies to PEG are generated in rabbits only if PEG is combined with highly immunogenic proteins[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 25322-68-3
-
Appearance Solid
-
Molecular Weight 3000.00
-
Color White to off-white
-
SMILES
[H]OCCO[H].[n]
-
Synonyms
Polyethylene glycol 3000
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
J Exp Clin Cancer Res
Elucidating the role of N-myristoylation in the excessive membrane localization of PD-L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy. [Abstract]2025 Jul 2;44(1):181. PMID: 40605065 -
EMBO Mol Med
Reelin-LRP8 signaling mediates brain dissemination of breast cancer cells via abluminal migration. [Abstract]2025 Jun 12. PMID: 40506610
Lösungsmittel & Löslichkeit
H2O : ≥ 125 mg/mL (41.67 mM)
* "≥" means soluble, but saturation unknown.
Reinheit & Dokumentation
-
Data Sheet (267 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Nasser Alhajj, et al. Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation. Asian J Pharm Sci. 2020, 15, 3. [Content Brief]
[2]. Harris JM, et al. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003 Mar;2(3):214-21. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 0.3333 mL | 1.6667 mL | 3.3333 mL | 8.3333 mL |
| 5 mM | 0.0667 mL | 0.3333 mL | 0.6667 mL | 1.6667 mL | |
| 10 mM | 0.0333 mL | 0.1667 mL | 0.3333 mL | 0.8333 mL | |
| 15 mM | 0.0222 mL | 0.1111 mL | 0.2222 mL | 0.5556 mL | |
| 20 mM | 0.0167 mL | 0.0833 mL | 0.1667 mL | 0.4167 mL | |
| 25 mM | 0.0133 mL | 0.0667 mL | 0.1333 mL | 0.3333 mL | |
| 30 mM | 0.0111 mL | 0.0556 mL | 0.1111 mL | 0.2778 mL | |
| 40 mM | 0.0083 mL | 0.0417 mL | 0.0833 mL | 0.2083 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
PEG3000 Related Classifications
HY-Y0873N Related Classifications
Powered by Bioz